Bayer Logo Bayer Logo Bayer Logo Bayer Logo

Dosing Information

Prophylatic Dosing

JIVI_Logo

Tailored prophylactic dosing to meet your patients’ need

Tailored prophylactic dosing

Please refer to local prescribing information. Not all patients are candidates for 1x weekly dosing. In non-EU countries other FVIII treatments may be available which also offer 1x weekly dosing

Confidence in your dosing choices

In the PROTECT VIII main study, protection was achieved with administered doses that were mostly at the lower end of the narrow recommended dose range for each infusion regimen.1,2*

Confidence in your dosing choices

* Low bleeding phenotype: 0 or 1 bleed (joint or muscle and no identified trauma) during the first 10 weeks of low-dose (25 IU/kg) Jivi twice weekly.1

High bleeding phenotype: 2 or more bleeds (joint or muscle and no identified trauma) during the first 10 weeks of low-dose (25 IU/kg) Jivi twice weekly.1

Mean values.1

References